
Astraea
AI Operating System for Clinical Development
Über das Unternehmen
Unternehmensbeschreibung auf Englisch
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Themen
- Standort
- San Francisco, CA, USA
- Teamgröße
- 6 Mitarbeitende
- YC-Batch
- Spring 2026
- Status
- Aktiv
- Phase
- Frühphase





